I am using some links to rfj's earlier posts from RPRX yahoo message board. I do have some questions on his views too, as he mentions RPRX as being worth $300-500 mil market cap in Oct (at least where share price should be) before the Dec results, and then after the third trial results this past week he mentions it should at least be $200-250 mil market cap, easy. rfj, did you become a little more cautious?
Ok, here are his links for what he thinks their shares should at least be trading, and then his thoughts on potential sales for their drugs which I believe depend on solid final March results from these trials. To summarize, he believes shares could trade up to the 20-30 range by mid-2007. I'm guessing the company could be sold for $500 mil or better (in parts) depending on final outcome of trials and additional trials needed, or around $50 if there is little share dilution.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.